Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Airship AI Holdings

• The Trade: Airship AI Holdings, Inc. AISP Director, CEO and Chairman of the BOD Victor Huang acquired a total of 60,000 shares an average price of $1.92. To acquire these shares, it cost around $114,917.
• What’s Happening: Airship AI recently started delivery of $10.9 million U.S. government contracts for advanced video and sensor management.
• What Airship AI Holdings Does: Airship AI Holdings Inc is a U.S.-owned and operated technology company. Airship AI is an AI-driven video, sensor and data management surveillance platform that improves public safety and operational efficiency for public sector and commercial customers by providing predictive analysis of events before it occur and meaningful intelligence to decision makers.

Lineage Cell Therapeutics

• The Trade: Lineage Cell Therapeutics, Inc. LCTX Director Anula Jayasuriya acquired a total of 10,000 shares at at an average price of $1.09. To acquire these shares, it cost around $10,900.
• What’s Happening: Lineage Cell Therapeutics, last month, submitted investigational new drug amendment to the FDA for OPC1 for the treatment of chronic and subacute spinal cord injury.
• What Lineage Cell Therapeutics Does: Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases.

Check This Out: How To Earn $500 A Month From Pfizer Stock

Globalstar

• The Trade: Globalstar, Inc. GSAT Director James F Lynch acquired a total of 500,000 shares at an average price of $1.93. The insider spent around $963,700 to buy those shares.
• What’s Happening: On Nov. 2, Globalstar reported third-quarter FY23 sales growth of 53% year-on-year to $57.7 million.
• What Globalstar Does: Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services.

Longeveron

• The Trade: Longeveron Inc. LGVN Director Khoso Baluch acquired a total of 10,000 shares at an average price of $1.43. The insider spent around 14,257 to buy those shares.
• What’s Happening: Longeveron recently announced a $2.36 million registered direct offering priced at-the-market under Nasdaq rules.
• What Longeveron Does: Longeveron Inc is a clinical-stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.

Don’t forget to check out our premarket coverage here